title: Results of fractionated TBI prior to bone marrow transplantation in standard risk leukaemia at Marseille.
abstract: One hundred and six patients with standard risk leukaemia were given fractionated TBI prior to allogeneic (72 cases, 27 of whom were T-depleted) or autologous (34 cases) bone marrow transplantation (BMT). Disease free survival at 5 years is 68% for allogeneic non T-depleted BMT and 33% for T-depleted BMT. Deaths are related to relapse, GVHD, infections, pneumonitis, encephalitis, VOD, AIDS, rejection.
authors: Institut J. Paoli-I.Calmettes, Marseille, France.
authors: M
authors: M
authors: Resbeut
authors: C
authors: C
authors: Altschuler
authors: D
authors: D
authors: Blaise
authors: D
authors: D
authors: Maraninchi
authors: A M
authors: AM
authors: Stoppa
authors: J P
authors: JP
authors: Guillet
authors: Y
authors: Y
authors: Carcassonne
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D006801:Humans; D007938:Leukemia / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D008212:Lymphocyte Depletion; D009364:Neoplasm Recurrence, Local; D011879:Radiotherapy Dosage; D013601:T-Lymphocytes; D014916:Whole-Body Irradiation / Q000379:methods*